In 1957, along with many countries in Eastern Europe, Romania liberalised its abortion law. The Soviet model of birth control made surgical abortion easily available, but put restrictions on access to modern contraceptives, leading to an exceptionally high abortion rate. By the mid-1960s there were 1 100 000 abortions performed each year in Romania, a lifetime [...]Read More Download PDF
Osur et al.’s Implementation of misoprostol for postabortion care in Kenya and Uganda: a qualitative evaluation
Osur and colleagues’ article on the evaluation findings of implementing misoprostol for post- abortion care (PAC) in Kenya and Uganda provides valuable lessons learned and best practices. Venture Strategies Innovations (VSI), a global health non-profit organization, is currently introducing misoprostol for PAC with the Ministries of Health (MOH) in Rwanda and Zimbabwe, and based on our ongoing implementation experiences, we would suggest a few additional lessons.Read More Download PDF
The largest absolute numbers of maternal deaths occur among the 40–50 million women who deliver annually without a skilled birth attendant. Most of these deaths occur in countries with a total fertility rate of greater than 4. The combination of global warming and rapid population growth in the Sahel and parts of the Middle East [...]Read More Download PDF
Background: The need for a concerted effort to address the gaps in family planning services for youth in sub-Saharan Africa has been underreported and underexplored.
Study Design: Trends in fertility, childbearing, unmet need for family planning options and contraceptive prevalence (CP) among youth are described with data from six African countries with four consecutive [...]
Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic review
Background: The use of intrauterine devices as a contraceptive method has been steadily growing in developing countries. Anemia in reproductive-age women is a growing concern in those settings.
Study Design: A systematic review of studies with measured hemoglobin and serum ferritin at baseline and after 1 year of use of copper intrauterine devices (IUDs) [...]
VSI in collaboration with local and international partner organizations conducted operations research (OR) across seven countries in Africa and Asia to determine the feasibility, acceptability, and program effectiveness of misoprostol use to prevent postpartum hemorrhage (PPH) at the community level. Developed for policy makers, stakeholders and researchers, the compendium includes an overview of the basic components of the OR model, country program summaries, and cross-cutting results and best practices to contribute to the growing evidence base on the community-level use of misoprostol to prevent PPH.Read More Download PDF
From health center to home, policy to practice, factory to pharmacy, VSI is "connecting women with care." Read more about VSI's collaborative efforts in 2011 and 2012 to expand women's access to life-saving medicines and services.Read More Download PDF
This brief summarizes the final results of a comprehensive postabortion care (PAC) pilot program conducted by the Rwanda Ministry of Health and VSI to address maternal deaths due to unsafe abortion. The results demonstrate that enabling mid-level providers at health centers to provide PAC through the integration of misoprostol as a treatment method increases the availability of PAC services and brings them closer to women.
For the brief in French, click here.
For the full technical report, click here.
The following report documents how, over the next 30 to 40 years in parts of sub- Saharan Africa, between 100 million and 200 million people are likely to be without sustainable food supplies. This was the conclusion of a multidisciplinary group of experts from Africa and North America, who asked what will happen in the [...]Read More Download PDF
The Angola Ministry of Health, in collaboration with VSI, conducted a demonstration project aimed at addressing maternal deaths due to complications from unsafe abortion. This research brief demonstrates that misoprostol is a safe, effective and feasible treatment method for incomplete abortion at all levels of the health system, including those facilities that do not have the capacity for manual vacuum aspiration or other surgical interventions.
For the full technical report in Portuguese, click here.